Antithrombotic Agents



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 18.5%
Antiplatelet Therapy 16.3%
Atrial Fibrillation 13.3%
Cerebrovascular Accident Prophylaxis 11.9%
Acute Coronary Syndrome 10.4%
Anticoagulant Therapy 8.1%
Hypertension 5.2%
Thrombosis Prophylaxis 3.7%
Percutaneous Coronary Intervention 3.0%
Iga Nephropathy 1.5%
Type 2 Diabetes Mellitus 1.5%
Acute Myocardial Infarction 0.7%
Hepatic Neoplasm Malignant 0.7%
Ischaemic Stroke Nos 0.7%
Lung Disorder 0.7%
Multiple Sclerosis 0.7%
Pain 0.7%
Product Used For Unknown Indication 0.7%
Prophylaxis Against Gastrointestinal Ulcer 0.7%
Renal Cell Carcinoma 0.7%
Atrial Fibrillation 19.0%
Embolic Stroke 9.5%
Haemorrhage 9.5%
Pulmonary Embolism 7.1%
Death 4.8%
Haemorrhage Intracranial 4.8%
Haemorrhoidal Haemorrhage 4.8%
International Normalised Ratio Fluctuation 4.8%
Joint Arthroplasty 4.8%
Pneumonia 4.8%
Renal Failure 4.8%
Cerebrovascular Accident 2.4%
Coronary Arterial Stent Insertion 2.4%
Drug Ineffective 2.4%
Epistaxis 2.4%
Gastrointestinal Haemorrhage 2.4%
Haemoptysis 2.4%
Injection Site Haemorrhage 2.4%
International Normalised Ratio Increased 2.4%
Menorrhagia 2.4%
Concomitant
Multiple Myeloma 15.7%
Hypertension 10.1%
Product Used For Unknown Indication 10.0%
Thrombosis Prophylaxis 8.6%
Type 2 Diabetes Mellitus 7.5%
Prophylaxis 5.1%
Colon Cancer 4.6%
Diabetes Mellitus 4.3%
Blood Pressure Abnormal 3.5%
Atrial Fibrillation 3.4%
Cardiac Disorder 3.1%
Smoking Cessation Therapy 3.1%
Nuclear Magnetic Resonance Imaging 3.0%
Imaging Procedure 2.9%
Prostate Cancer 2.9%
Bone Pain 2.7%
Infection Prophylaxis 2.7%
Infection 2.4%
Pulmonary Arterial Hypertension 2.4%
Angiogram 2.2%
Renal Failure Acute 12.6%
Renal Failure 8.1%
Thrombocytopenia 7.2%
Dyspnoea 6.3%
Cardiac Failure Congestive 5.4%
Death 5.4%
Depression 4.5%
International Normalised Ratio Increased 4.5%
Myocardial Infarction 4.5%
Nausea 4.5%
Weight Decreased 4.5%
Cerebral Haemorrhage 3.6%
Cerebral Infarction 3.6%
General Physical Health Deterioration 3.6%
Hepatitis 3.6%
Melaena 3.6%
Neutropenia 3.6%
Pain In Extremity 3.6%
Palpitations 3.6%
Pulmonary Embolism 3.6%